Literature DB >> 10434278

Effect of different acids on solid-state stability of an ester prodrug of a IIb/IIIa glycoprotein receptor antagonist.

S I Badawy1, R C Williams, D L Gilbert.   

Abstract

DMP 754 is an ester prodrug of a fibrinogen glycoprotein IIb/IIIa receptor antagonist. The purpose of this study was to determine whether the addition of acids to blends containing DMP 754 and anhydrous lactose could improve the stability at 40 degrees C/75% relative humidity. DMP 754 drug substance was stable at this accelerated condition. Blending of DMP 754 with anhydrous lactose accelerated the hydrolysis of both the ester and the amidine groups. The pH of a saturated solution of lactose is approximately 6, whereas the pH of maximum solution stability for the drug substance is approximately 4. Acids were incorporated into the blend so that the microenvironment would be more acidic and afford improved drug stability. Addition of acids decreased the rate of hydrolysis of the amidine group and this effect was more pronounced with stronger acids. However, the more acidic ingredients led to more rapid hydrolysis of the ester group.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10434278     DOI: 10.1081/pdt-100101368

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  9 in total

Review 1.  Impact of excipient interactions on solid dosage form stability.

Authors:  Ajit S Narang; Divyakant Desai; Sherif Badawy
Journal:  Pharm Res       Date:  2012-06-16       Impact factor: 4.200

2.  Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation.

Authors:  Jeremy M Merritt; Shekhar K Viswanath; Gregory A Stephenson
Journal:  Pharm Res       Date:  2012-08-24       Impact factor: 4.200

3.  Ionization states in the microenvironment of solid dosage forms: effect of formulation variables and processing.

Authors:  Ramprakash Govindarajan; Andrey Zinchuk; Bruno Hancock; Evgenyi Shalaev; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

4.  Chemical stabilization of a Delta9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: role of microenvironment pH.

Authors:  Manish Munjal; Mahmoud A ElSohly; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2006-09-01       Impact factor: 3.246

5.  Polymeric systems for amorphous Delta9-tetrahydrocannabinol produced by a hot-melt method. Part II: Effect of oxidation mechanisms and chemical interactions on stability.

Authors:  Manish Munjal; Mahmoud A Elsohly; Michael A Repka
Journal:  J Pharm Sci       Date:  2006-11       Impact factor: 3.534

6.  Influence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices.

Authors:  Sridhar Thumma; Mahmoud A ElSohly; Shuang-Qing Zhang; Waseem Gul; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2008-06-18       Impact factor: 5.571

7.  Chemical stability and bioadhesive properties of an ester prodrug of Delta 9-tetrahydrocannabinol in poly(ethylene oxide) matrices: effect of formulation additives.

Authors:  Sridhar Thumma; Soumyajit Majumdar; Mahmoud A ElSohly; Waseem Gul; Michael A Repka
Journal:  Int J Pharm       Date:  2008-07-05       Impact factor: 5.875

8.  Development and In Vitro-In Vivo Evaluation of a Novel Sustained-Release Loxoprofen Pellet with Double Coating Layer.

Authors:  Dongwei Wan; Min Zhao; Jingjing Zhang; Libiao Luan
Journal:  Pharmaceutics       Date:  2019-06-05       Impact factor: 6.321

Review 9.  Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics.

Authors:  Ruipeng Mu; Jiaqi Yuan; Yue Huang; John K Meissen; Si Mou; Meina Liang; Anton I Rosenbaum
Journal:  BioDrugs       Date:  2022-04-01       Impact factor: 7.744

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.